We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Hepatitis A virus: serology and molecular diagnostics

    Anne Marie Roque-Afonso

    † Author for correspondence

    Centre National de Référence pour les Virus à Transmission Entérique, AP-HP, Hôpital Paul Brousse, Laboratoire de Virologie, Villejuif, 94804, France.

    ,
    Delphine Desbois

    Centre National de Référence pour les Virus à Transmission Entérique, AP-HP, Hôpital Paul Brousse, Laboratoire de Virologie, Villejuif, 94804, France.

    &
    Elisabeth Dussaix

    Centre National de Référence pour les Virus à Transmission Entérique, AP-HP, Hôpital Paul Brousse, Laboratoire de Virologie, Villejuif, 94804, France.

    Published Online:https://doi.org/10.2217/fvl.10.9

    The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver enzymes or its detection during polyclonal activation of the immune system due to unrelated viral infection or autoimmune diseases. Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link to other cases. Molecular epidemiology allows us to determine whether viruses from different locations are related to each other and provides further understanding of viral epidemiology by identifying sources and transmission modes. It has been demonstrated that the rapid turnover of HAV strains in low-endemicity countries is caused by their introduction by travelers. Growing sequence databases allow for the identification of geographic origin of viral strains. Collaboration between surveillance laboratories, including database sharing, should be promoted for deeper investigation of outbreaks and improved prevention approaches.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    Bibliography

    • Cuthbert JA: Hepatitis A: old and new. Clin. Microbiol. Rev.14(1),38–58 (2001).▪ Detailed review of epidemiological, clinical and pathophysiological features of hepatitis A virus (HAV) infection
    • Jacobsen KH, Koopman JS: Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol. Infect.132(6),1005–1022 (2004).
    • Wasley A, Grytdal S, Gallagher K: Surveillance for acute viral hepatitis – United States, 2006. MMWR Surveill. Summ.57(2),1–24 (2008).
    • Roque-Afonso AM, Grangeot-Keros L, Roquebert B et al.: Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus. J. Clin. Microbiol.42(11),5121–5124 (2004).
    • Stapleton JT: Host immune response to hepatitis A virus. J. Infect. Dis.171(Suppl.) 1S9–1S14 (1995).
    • Nainan OV, Xia G, Vaughan G, Margolis HS: Diagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev.19(1),63–79 (2006).▪▪ Detailed review on molecular epidemiology of HAV.
    • Lemon SM, Jansen RW, Brown EA: Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine10(Suppl.),1S40–1S44 (1992).
    • Fiore AE, Wasley A, Bell BP: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-7),1–23 (2006).
    • de Paula VS, Villar LM, Morais LM, Lewis-Ximenez LL, Niel C, Gaspar AM: Detection of hepatitis A virus RNA in serum during the window period of infection. J. Clin. Virol.29(4),254–259 (2004).
    • 10  Bower WA, Nainan OV, Han X, Margolis HS: Duration of viremia in hepatitis A virus infection. J. Infect. Dis.182(1),12–17 (2000).▪ First insight into the duration of HAV viremia by molecular techniques.
    • 11  Costa-Mattioli M, Monpoeho S, Nicand E, Aleman MH, Billaudel S, Ferre V: Quantification and duration of viraemia during hepatitis A infection as determined by real-time RT-PCR. J. Viral Hepat.9(2),101–106 (2002).
    • 12  Yotsuyanagi H, Koike K, Yasuda K et al.: Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction. Hepatology24(1),10–13 (1996).
    • 13  Costa-Mattioli M, Allavena C, Poirier AS, Billaudel S, Raffi F, Ferre V: Prolonged hepatitis A infection in an HIV-1 seropositive patient. J. Med. Virol.68(1),7–11 (2002).
    • 14  Polish LB, Robertson BH, Khanna B et al.: Excretion of hepatitis A virus (HAV) in adults: comparison of immunologic and molecular detection methods and relationship between HAV positivity and infectivity in tamarins. J. Clin. Microbiol.37(11),3615–3617 (1999).
    • 15  Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D: Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore)71(1),14–23 (1992).
    • 16  Sagnelli E, Coppola N, Marrocco C et al.: HAV replication in acute hepatitis with typical and atypical clinical course. J. Med. Virol.71(1),1–6 (2003).
    • 17  Fainboim L, Canero Velasco MC, Marcos CY et al.: Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology33(6),1512–1517 (2001).
    • 18  Gordon SC, Reddy KR, Schiff L, Schiff ER: Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann. Intern. Med.101(5),635–637 (1984).
    • 19  Vallbracht A, Maier K, Stierhof YD, Wiedmann KH, Flehmig B, Fleischer B: Liver-derived cytotoxic T cells in hepatitis A virus infection. J. Infect. Dis.160(2),209–217 (1989).
    • 20  Willner IR, Uhl MD, Howard SC, Williams EQ, Riely CA, Waters B: Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann. Intern. Med.128(2),111–114 (1998).
    • 21  Rezende G, Roque-Afonso AM, Samuel D et al.: Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology38(3),613–618 (2003).
    • 22  Wiedmann M, Boehm S, Schumacher W, Swysen C, Zauke M: Evaluation of three commercial assays for the detection of hepatitis a virus. Eur. J. Clin. Microbiol. Infect. Dis.22(2),129–130 (2003).
    • 23  Roque-Afonso AM, Mackiewicz V, Dussaix E: Detection of immunoglobulin M antibody to hepatitis A virus in patients without acute hepatitis A: the usefulness of specific immunoglobulin G avidity. Clin. Infect. Dis.42(6),887–888 (2006).
    • 24  Syhavong B RB, Smythe L, Rolain J-M et al.: The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Trans. R. Soc. Trop. Med. Hyg. (2010) (In press).
    • 25  Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN: Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J. Med. Virol.40(1),22–27 (1993).
    • 26  Just M, Berger R: Reactogenicity and immunogenicity of inactivated hepatitis A vaccines. Vaccine10(Suppl.),1S110–1S113 (1992).
    • 27  Joshi MS, Chitambar SD, Arankalle VA, Chadha MS: Evaluation of urine as a clinical specimen for diagnosis of hepatitis A. Clin. Diagn. Lab. Immunol.9(4),840–845 (2002).
    • 28  Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW: A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am. J. Epidemiol.159(8),786–794 (2004).
    • 29  Pina S, Buti M, Jardi R, Clemente-Casares P, Jofre J, Girones R: Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J. Gen. Virol.82(Pt 12),2955–2963 (2001).▪▪ Results of a 5–7 year surveillance of HAV strains from environmental and clinical samples in south Italy. Highlights the existence of an environmental reservoir of HAV.
    • 30  Mackiewicz V, Dussaix E, Le Petitcorps MF, Roque-Afonso AM: Detection of hepatitis A virus RNA in saliva. J. Clin. Microbiol.42(9),4329–4331 (2004).
    • 31  Sanchez G, Bosch A, Pinto RM: Hepatitis A virus detection in food: current and future prospects. Lett. Appl. Microbiol.45(1),1–5 (2007).
    • 32  Desbois D, Roque-Afonso AM, Lebraud P, Dussaix E: Use of dried serum spots for serological and molecular detection of hepatitis a virus. J. Clin. Microbiol.47(5),1536–1542 (2009).
    • 33  Amado LA, Villar LM, de Paula VS, Gaspar AM: Comparison between serum and saliva for the detection of hepatitis A virus RNA. J. Virol. Methods148(1–2),74–80 (2008).
    • 34  Jorquera JI: Safety procedures of coagulation factors. Haemophilia13(Suppl.),541–546 (2007).
    • 35  Heitmann A, Laue T, Schottstedt V, Dotzauer A, Pichl L: Occurrence of hepatitis A virus genotype III in Germany requires the adaptation of commercially available diagnostic test systems. Transfusion45(7),1097–1105 (2005).
    • 36  Sanchez G, Populaire S, Butot S, Putallaz T, Joosten H: Detection and differentiation of human hepatitis A strains by commercial quantitative real-time RT-PCR tests. J. Virol. Methods132(1–2),160–165 (2006).
    • 37  Jones TH, Brassard J, Johns MW, Gagne MJ: The effect of pre-treatment and sonication of centrifugal ultrafiltration devices on virus recovery. J. Virol. Methods161(2),199–204 (2009).
    • 38  Bosch A, Guix S, Sano D, Pinto RM: New tools for the study and direct surveillance of viral pathogens in water. Curr. Opin. Biotechnol.19(3),295–301 (2008).▪ Review on the technical difficulties and requirements for virus detection from water samples.
    • 39  Goswami BB, Burkhardt W 3rd, Cebula TA: Identification of genetic variants of hepatitis A virus. J. Virol. Methods65(1),95–103 (1997).
    • 40  Mackiewicz V, Roque-Afonso AM, Marchadier E, Nicand E, Fki-Berrajah L, Dussaix E: Rapid investigation of hepatitis A virus outbreak by single strand conformation polymorphism analysis. J. Med. Virol.76(2),271–278 (2005).
    • 41  Robertson BH, Jansen RW, Khanna B et al.: Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol.73(Pt 6),1365–1377 (1992).
    • 42  Costa-Mattioli M, Cristina J, Romero H et al.: Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol.76(18),9516–9525 (2002).▪▪ A total of 81 sequences of the VP1 gene from strains with specified geographical origin. New data on worldwide genotypes distribution with a more accurate strain determination.
    • 43  Lu L, Ching KZ, de Paula VS et al.: Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J. Gen. Virol.85(Pt 10),2943–2952 (2004).
    • 44  Nainan OV, Armstrong GL, Han XH, Williams I, Bell BP, Margolis HS: Hepatitis a molecular epidemiology in the United States, 1996–1997: sources of infection and implications of vaccination policy. J. Infect. Dis.191(6),957–963 (2005).
    • 45  Hutin YJ, Pool V, Cramer EH et al.: A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N. Engl. J. Med.340(8),595–602 (1999).
    • 46  Jansen RW, Siegl G, Lemon SM: Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc. Natl Acad. Sci. USA.87(8),2867–2871 (1990).
    • 47  Joshi MS, Walimbe AM, Chitambar SD: Evaluation of genomic regions of hepatitis A virus for phylogenetic analysis: Suitability of the 2C region for genotyping. J. Virol. Methods153(1),36–42 (2008).
    • 48  Bruisten SM, van Steenbergen JE, Pijl AS, Niesters HG, van Doornum GJ, Coutinho RA: Molecular epidemiology of hepatitis A virus in Amsterdam, The Netherlands. J. Med. Virol.63(2),88–95 (2001).
    • 49  Costa-Mattioli M, di Napoli A, Ferre V, Billaudel S, Perez-Bercoff R, Cristina J: Genetic variability of hepatitis A virus. J. Gen. Virol.84(Pt 12),3191–3201 (2003).
    • 50  Normann A, Badur S, Onel D et al.: Acute hepatitis A virus infection in Turkey. J. Med. Virol.80(5),785–790 (2008).
    • 51  Song HU, Hwang SG, Kwon CI et al.: Molecular epidemiology of hepatitis A virus in the South-East area of Gyeonggi-do in Korea. Yonsei Med. J.50(4),512–516 (2009).
    • 52  Tjon GM, Wijkmans CJ, Coutinho RA et al.: Molecular epidemiology of hepatitis A in Noord-Brabant, The Netherlands. J. Clin. Virol.32(2),128–136 (2005).
    • 53  Amon JJ, Devasia R, Xia G et al.: Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J. Infect. Dis.192(8),1323–1330 (2005).
    • 54  Wheeler C, Vogt TM, Armstrong GL et al.: An outbreak of hepatitis A associated with green onions. N. Engl. J. Med.353(9),890–897 (2005).
    • 55  Villar LM, de Paula VS, Diniz-Mendes L et al.: Molecular detection of hepatitis A virus in urban sewage in Rio de Janeiro, Brazil. Lett. Appl. Microbiol.45(2),168–173 (2007).
    • 56  Divizia M, Gabrieli R, Macaluso A et al.: Nucleotide correlation between HAV isolates from human patients and environmental samples. J. Med. Virol.75(1),8–12 (2005).
    • 57  Kittigul L, Uthaisin A, Ekchaloemkiet S, Utrarachkij F, Luksamijarulkul P: Detection and characterization of hepatitis A virus in water samples in Thailand. J. Appl. Microbiol.100(6),1318–1323 (2006).
    • 58  Arankalle VA, Sarada Devi KL, Lole KS, Shenoy KT, Verma V, Haneephabi M: Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. Indian J. Med. Res.123(6),760–769 (2006).
    • 59  Nenonen NP, Hernroth B, Chauque AA, Hannoun C, Bergstrom T: Detection of hepatitis A virus genotype IB variants in clams from Maputo Bay, Mozambique. J. Med. Virol.78(7),896–905 (2006).
    • 60  Arraj A, Bohatier J, Aumeran C, Bailly JL, Laveran H, Traore O: An epidemiological study of enteric viruses in sewage with molecular characterization by RT-PCR and sequence analysis. J. Water Health6(3),351–358 (2008).
    • 61  Le Guyader F, Haugarreau L, Miossec L, Dubois E, Pommepuy M: Three-year study to assess human enteric viruses in shellfish. Appl. Environ. Microbiol.66(8),3241–3248 (2000).
    • 62  De Serres G, Cromeans TL, Levesque B et al.: Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J. Infect. Dis.179(1),37–43 (1999).▪▪ Detailed investigation of a waterborne outbreak in a low-endemicity area. Identification of the transmission chain.
    • 63  Fiore AE: Hepatitis A transmitted by food. Clin. Infect. Dis.38(5),705–715 (2004).
    • 64  Halliday ML, Kang LY, Zhou TK et al.: An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis.164(5),852–859 (1991).
    • 65  Tjon G, Xiridou M, Coutinho R, Bruisten S: Different transmission patterns of hepatitis A virus for two main risk groups as evidenced by molecular cluster analysis. J. Med. Virol.79(5),488–494 (2007).
    • 66  Santa-Olalla P, Roque-Afonso A, Couturier E et al.: Utilisation de tests salivaires dans l’investigation d’une épidémie d’hépatite A, Auvergne, décembre 2004. Bull. Epidemiol. Hebd.2 –313–315 (2006).
    • 67  Tallo T, Norder H, Tefanova V et al.: Sequential changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J. Med. Virol.70(2),187–193 (2003).
    • 68  Stene-Johansen K, Tjon G, Schreier E et al.: Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J. Med. Virol.79(4),356–365 (2007).▪▪ Illustrates the transmission of HAV among networks of persons with similar risk factors for infection.
    • 69  Sundkvist T, Aitken C, Duckworth G, Jeffries D: Outbreak of acute hepatitis A among homosexual men in East London. Scand. J. Infect. Dis.29(3),211–212 (1997).
    • 70  Couturier E, Roque-Afonso AM, Letort MJ, Dussaix E, Vaillant V, de Valk H: Cluster of cases of hepatitis A with a travel history to Egypt, September–November 2008, France. Euro Surveill.14(3),19094 (2009).
    • 71  Robesyn E, Micalessi MI, Quoilin S, Naranjo M, Thomas I: Cluster of hepatitis A cases among travellers returning from Egypt, Belgium, September through November 2008. Euro Surveill.14(3),19095 (2009).
    • 72  Demicheli V, Tiberti D: The effectiveness and safety of hepatitis A vaccine: a systematic review. Vaccine21(19–20),2242–2245 (2003).
    • 73  Sanchez G, Pinto RM, Vanaclocha H, Bosch A: Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak. J. Clin. Microbiol.40(11),4148–4155 (2002).